Anteris Technologies Global Corp. Common Stock (AVR) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $8.16 (-3.09%), Market cap $0.64B, 52-week low–high $2.90 ~ $6.69.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable
Financial statements, price targets, institutional (13F) holdings and related news for Anteris Technologies Global Corp. Common Stock are updated in real time on BlackAll Trade.
Anteris Technologies Global Corp. Common Stock trades at $8.16 (-3.09%). Real-time quotes and charts are available on BlackAll Trade.
Anteris Technologies Global Corp. Common Stock has a market cap of about $0.64B.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart va